TRIM54 alleviates inflammation and apoptosis by stabilizing YOD1 in rat tendon-derived stem cells
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2023.105510 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Hua Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Endopeptidases, Tendinopathy, Thiolester Hydrolases, Muscle Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Health Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tendinopathy is a disorder of musculoskeletal system that primarily affects athletes and the elderly. Current treatment options are generally comprised of various exercise and loading programs, therapeutic modalities, and surgical interventions and are limited to pain management. This study is to understand the role of TRIM54 (tripartite motif containing 54) in tendonitis through in vitro modeling with tendon-derived stem cells (TDSCs) and in vivo using rat tendon injury model. Initially, we observed that TRIM54 overexpression in TDSCs model increased stemness and decreased apoptosis. Additionally, it rescued cells from tumor necrosis factor α-induced inflammation, migration, and tenogenic differentiation. Further, through immunoprecipitation studies, we identified that TRIM54 regulates inflammation in TDSCs by binding to and ubiquitinating YOD1. Further, overexpression of TRIM54 improved the histopathological score of tendon injury as well as the failure load, stiffness, and young modulus in vivo. These results indicated that TRIM54 played a critical role in reducing the effects of tendon injury. Consequently, these results shed light on potential therapeutic alternatives for treating tendinopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Orthopaedic Surgery, Hainan Province Clinical Medical Center, Sanya, China; Haikou Orthopedic and Diabetes Hospital of Shanghai Sixth People's Hospital, Haikou, China.
- Department of Nuclear Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
- Department of Radiology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Department of Radiology, Ruijin Hospital Luwan Branch, School of Medicine, Shanghai Jiao Tong University, Sha…
- Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: drsunyb@fudan.ed…
- The Institute of Intervention Vessel, Tongji University School of Medicine, Shanghai, China.
Förderung
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
Zitieren
APA
Chen, H., Chen, X., Yang, L., Sheng, S., Yang, J., Lu, Y., Sun, Y., Zhang, X., & Jiang, C. (2024). TRIM54 alleviates inflammation and apoptosis by stabilizing YOD1 in rat tendon-derived stem cells. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105510
Vancouver
Chen H, Chen X, Yang L, Sheng S, Yang J, Lu Y, et al. TRIM54 alleviates inflammation and apoptosis by stabilizing YOD1 in rat tendon-derived stem cells. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2023.105510
BibTeX
@article{Chen2024,
author = {Chen, Hua and Chen, Xiaofeng and Yang, Ling and Sheng, Shiyang and Yang, Jianshe and Lu, Yong and Sun, Yangbai and Zhang, Xiaoping and Jiang, Chaoyin},
title = {TRIM54 alleviates inflammation and apoptosis by stabilizing YOD1 in rat tendon-derived stem cells},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2023.105510}
}
EUVIMED